XARACOLL

Peak

bupivacaine hydrochloride

NDAIMPLANTATIONIMPLANT
Approved
Aug 2020
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Jan 9, 2033
83 months away
Patent Expiry
Jan 9, 2033

Patent Records (2)

Patent #ExpiryTypeUse Code
RE47826
May 20, 2029
U-2949
11746141
Jan 9, 2033
Product
—
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers